Continuous Flow Synthesis of Anticancer Drugs

Area of Science:

• Medicinal Chemistry
• Chemical Engineering
• Process Chemistry

Background:

• Continuous flow chemistry is a well-established synthesis technology offering advantages over batch processes, including superior heat/mass transfer, enhanced control, safety, and a smaller footprint.
• Flow chemistry allows for the integration of in-line analysis and purification, enabling telescoped reaction sequences.
• The application of continuous flow protocols in pharmaceutical synthesis, particularly for complex molecules, is a growing area of research.

Purpose of the Study:

• To review the latest developments in continuous flow chemistry for anticancer drug synthesis.
• To highlight key case studies of continuous flow synthesis of anticancer agents or their precursors.
• To showcase the impact and potential of flow chemistry in generating important anticancer drugs.

Main Methods:

• Literature review focusing on publications from 2016-2021.
• Analysis of case studies detailing the continuous synthesis of anticancer drug active pharmaceutical ingredients (APIs) or key building blocks.
• Evaluation of reported benefits and challenges of applying flow chemistry in this domain.

Main Results:

• Continuous flow protocols have been successfully applied to the synthesis of various anticancer drug candidates and their intermediates.
• Key advantages such as improved safety, scalability, and efficiency were demonstrated in several case studies.
• The integration of flow chemistry enables more streamlined and potentially cost-effective production routes.

Conclusions:

• Continuous flow chemistry is a powerful tool for the efficient and safe synthesis of anticancer drugs.
• Recent advancements demonstrate its significant impact on the generation of vital pharmaceutical compounds.
• Further exploration and adoption of flow chemistry are encouraged for the development of novel anticancer therapeutics.